5,6-methylenedioxy-2-aminoindane has been researched along with Serotonin Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balíková, M; Čegan, M; Himl, M; Horsley, RR; Kuchař, M; Lhotková, E; Mikšátková, P; Páleníček, T; Tylš, F; Valeš, K; Žídková, M | 1 |
1 other study(ies) available for 5,6-methylenedioxy-2-aminoindane and Serotonin Syndrome
| Article | Year |
|---|---|
Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats.
Topics: Animals; Body Temperature Regulation; Brain; Habituation, Psychophysiologic; Heart; Indans; Lethal Dose 50; Male; Motor Activity; Myocardium; Prepulse Inhibition; Psychotropic Drugs; Rats, Wistar; Saliva; Serotonin Syndrome; Sweating | 2016 |